RevAssist®
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 31 (9), 743-752
- https://doi.org/10.2165/00002018-200831090-00003
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Evaluation of the developmental toxicity of lenalidomide in rabbitsBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2007
- Can We Ensure the Safe Use of Known Human Teratogens?Drug Safety, 2007
- Risk minimization practices for pregnancy prevention: understanding risk, selecting toolsPharmacoepidemiology and Drug Safety, 2006
- Thalidomide Use in the USDrug Safety, 2006
- Diagnostic Considerations in the Measurement of Human Chorionic Gonadotropin in Aging WomenClinical Chemistry, 2005
- Risk Management Strategies in the Postmarketing PeriodDrug Safety, 2005
- S.T.E.P.S.™: A comprehensive program for controlling and monitoring access to thalidomideClinical Therapeutics, 1999
- Serum Levels of Human Chorionic Gonadotropin in Nonpregnant Women and Men Are Modulated by Gonadotropin-Releasing Hormone and Sex Steroids*Journal of Clinical Endocrinology & Metabolism, 1987